Two soluble forms of β1,4-galactosyltransferase released from ovarian cancer cells and from COS-1 cells transfected with its cDNA

Daisuke Aoki, Eiko Saitoh, Yumi Matsumoto, Eiichirou Tominaga, Akira Hirasawa, Nobuyuki Susumu, Yasuhiro Udagawa, Shiro Nozawa

研究成果: Article

抄録

Employing RMG-1 cells derived from human ovarian adenocarcinoma and COS-1 cells transfected with cDNA for β1,4-galactosyltransferase, we first investigated the intracellular localization of this enzyme and secondly assayed separately the two types of soluble forms of it (designated as normal GaIT and GAT) in their culture supernatants. As results, the binding of anti-β1,4-galactosyltransferase monoclonal antibody was strongly positive at the Golgi area surrounding nuclei and the staining pattern was the same between RMG-1 cells and COS-1 transformants. These data demonstrated that the cells were producing β1,4-galactosyltransferase and had the ability to release it into the culture medium. As for the two soluble forms released from the cells, they were simultaneously detected in the culture medium by Western blotting and enzyme immunoassay using monoclonal antibodies, i.e., Mab8628 reactive to both GAT and normal-GaIT and Mab8513 specific for GAT, indicating that both were derived from RMG-1 and from the cDNA introduced into COS-1 cells. Since serum-GAT clinically reflects tumor growth more accurately or specifically than normal GaIT does, RMG-1 and COS-1 cells having cDNA for β1,4-galactosyltransferase would be promising as sources of these enzymes in order to investigate the differences in the behaviors of normal GaIT and GAT associated with ovarian malignant tumors.

元の言語English
ページ(範囲)209-214
ページ数6
ジャーナルActa Histochemica et Cytochemica
32
発行部数3
出版物ステータスPublished - 1999

Fingerprint

Galactosyltransferases
COS Cells
Ovarian Neoplasms
Complementary DNA
Cells
Culture Media
Tumors
Enzymes
Monoclonal Antibodies
Aptitude
Immunoenzyme Techniques
Neoplasms
Adenocarcinoma
Western Blotting
GAT
Staining and Labeling
Growth
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology
  • Anatomy
  • Neuroscience(all)

これを引用

Two soluble forms of β1,4-galactosyltransferase released from ovarian cancer cells and from COS-1 cells transfected with its cDNA. / Aoki, Daisuke; Saitoh, Eiko; Matsumoto, Yumi; Tominaga, Eiichirou; Hirasawa, Akira; Susumu, Nobuyuki; Udagawa, Yasuhiro; Nozawa, Shiro.

:: Acta Histochemica et Cytochemica, 巻 32, 番号 3, 1999, p. 209-214.

研究成果: Article

Aoki, Daisuke ; Saitoh, Eiko ; Matsumoto, Yumi ; Tominaga, Eiichirou ; Hirasawa, Akira ; Susumu, Nobuyuki ; Udagawa, Yasuhiro ; Nozawa, Shiro. / Two soluble forms of β1,4-galactosyltransferase released from ovarian cancer cells and from COS-1 cells transfected with its cDNA. :: Acta Histochemica et Cytochemica. 1999 ; 巻 32, 番号 3. pp. 209-214.
@article{243d70d8338a4bebb82985ab73ee7616,
title = "Two soluble forms of β1,4-galactosyltransferase released from ovarian cancer cells and from COS-1 cells transfected with its cDNA",
abstract = "Employing RMG-1 cells derived from human ovarian adenocarcinoma and COS-1 cells transfected with cDNA for β1,4-galactosyltransferase, we first investigated the intracellular localization of this enzyme and secondly assayed separately the two types of soluble forms of it (designated as normal GaIT and GAT) in their culture supernatants. As results, the binding of anti-β1,4-galactosyltransferase monoclonal antibody was strongly positive at the Golgi area surrounding nuclei and the staining pattern was the same between RMG-1 cells and COS-1 transformants. These data demonstrated that the cells were producing β1,4-galactosyltransferase and had the ability to release it into the culture medium. As for the two soluble forms released from the cells, they were simultaneously detected in the culture medium by Western blotting and enzyme immunoassay using monoclonal antibodies, i.e., Mab8628 reactive to both GAT and normal-GaIT and Mab8513 specific for GAT, indicating that both were derived from RMG-1 and from the cDNA introduced into COS-1 cells. Since serum-GAT clinically reflects tumor growth more accurately or specifically than normal GaIT does, RMG-1 and COS-1 cells having cDNA for β1,4-galactosyltransferase would be promising as sources of these enzymes in order to investigate the differences in the behaviors of normal GaIT and GAT associated with ovarian malignant tumors.",
keywords = "β1,4-galactosyltransferase, Immunofluorography, RMG-1, Soluble form, Transfection",
author = "Daisuke Aoki and Eiko Saitoh and Yumi Matsumoto and Eiichirou Tominaga and Akira Hirasawa and Nobuyuki Susumu and Yasuhiro Udagawa and Shiro Nozawa",
year = "1999",
language = "English",
volume = "32",
pages = "209--214",
journal = "Acta Histochemica et Cytochemica",
issn = "0044-5991",
publisher = "Japan Society of Histochemistry and Cytochemistry",
number = "3",

}

TY - JOUR

T1 - Two soluble forms of β1,4-galactosyltransferase released from ovarian cancer cells and from COS-1 cells transfected with its cDNA

AU - Aoki, Daisuke

AU - Saitoh, Eiko

AU - Matsumoto, Yumi

AU - Tominaga, Eiichirou

AU - Hirasawa, Akira

AU - Susumu, Nobuyuki

AU - Udagawa, Yasuhiro

AU - Nozawa, Shiro

PY - 1999

Y1 - 1999

N2 - Employing RMG-1 cells derived from human ovarian adenocarcinoma and COS-1 cells transfected with cDNA for β1,4-galactosyltransferase, we first investigated the intracellular localization of this enzyme and secondly assayed separately the two types of soluble forms of it (designated as normal GaIT and GAT) in their culture supernatants. As results, the binding of anti-β1,4-galactosyltransferase monoclonal antibody was strongly positive at the Golgi area surrounding nuclei and the staining pattern was the same between RMG-1 cells and COS-1 transformants. These data demonstrated that the cells were producing β1,4-galactosyltransferase and had the ability to release it into the culture medium. As for the two soluble forms released from the cells, they were simultaneously detected in the culture medium by Western blotting and enzyme immunoassay using monoclonal antibodies, i.e., Mab8628 reactive to both GAT and normal-GaIT and Mab8513 specific for GAT, indicating that both were derived from RMG-1 and from the cDNA introduced into COS-1 cells. Since serum-GAT clinically reflects tumor growth more accurately or specifically than normal GaIT does, RMG-1 and COS-1 cells having cDNA for β1,4-galactosyltransferase would be promising as sources of these enzymes in order to investigate the differences in the behaviors of normal GaIT and GAT associated with ovarian malignant tumors.

AB - Employing RMG-1 cells derived from human ovarian adenocarcinoma and COS-1 cells transfected with cDNA for β1,4-galactosyltransferase, we first investigated the intracellular localization of this enzyme and secondly assayed separately the two types of soluble forms of it (designated as normal GaIT and GAT) in their culture supernatants. As results, the binding of anti-β1,4-galactosyltransferase monoclonal antibody was strongly positive at the Golgi area surrounding nuclei and the staining pattern was the same between RMG-1 cells and COS-1 transformants. These data demonstrated that the cells were producing β1,4-galactosyltransferase and had the ability to release it into the culture medium. As for the two soluble forms released from the cells, they were simultaneously detected in the culture medium by Western blotting and enzyme immunoassay using monoclonal antibodies, i.e., Mab8628 reactive to both GAT and normal-GaIT and Mab8513 specific for GAT, indicating that both were derived from RMG-1 and from the cDNA introduced into COS-1 cells. Since serum-GAT clinically reflects tumor growth more accurately or specifically than normal GaIT does, RMG-1 and COS-1 cells having cDNA for β1,4-galactosyltransferase would be promising as sources of these enzymes in order to investigate the differences in the behaviors of normal GaIT and GAT associated with ovarian malignant tumors.

KW - β1,4-galactosyltransferase

KW - Immunofluorography

KW - RMG-1

KW - Soluble form

KW - Transfection

UR - http://www.scopus.com/inward/record.url?scp=0032799423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032799423&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032799423

VL - 32

SP - 209

EP - 214

JO - Acta Histochemica et Cytochemica

JF - Acta Histochemica et Cytochemica

SN - 0044-5991

IS - 3

ER -